Journal of Cancer Chemotherapy

About the Journal

Cancer chemotherapy is a cornerstone of modern oncology, involving the use of powerful drugs to destroy cancer cells or inhibit their growth and spread. It targets rapidly dividing cells, a hallmark of cancer, and may be administered orally, intravenously, or through other delivery systems. Chemotherapy can be used alone or in combination with other treatments such as surgery, radiation therapy, immunotherapy, or targeted therapy, depending on the cancer type, stage, and patient condition.

The goals of chemotherapy vary curative, palliative, or to shrink tumors before surgery (neoadjuvant) or after surgery to prevent recurrence (adjuvant). Despite its effectiveness, chemotherapy can cause side effects due to its impact on healthy cells, necessitating careful dosing and supportive care.

Advancements in drug development, delivery mechanisms, and personalized medicine are continuously improving the efficacy and tolerability of chemotherapy. Research is also focusing on minimizing resistance, enhancing tumor specificity, and integrating chemotherapy with precision oncology strategies for better clinical outcomes.

Authors are requested to submit manuscripts online at Submit Manuscript or Send as an e-mail attachment to the Editorial Office at editor@globalmeetx.net

Rapid Publication Service

Globalmeetx Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.

The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.

Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.

Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.

Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.